Another drug target that could potentially promote a reduction in P. aeruginosa ocular infection and, hence, mitigate its biofilm formation is high mobility group box 1 (HMGB1), according to Hazlett et al. [109]. This evidence concerns the gene HMGB1 and eye infection.